ACCREDO HEALTH

Welcome to the Brand page for “ACCREDO HEALTH”, which is offered here for Providing patient educational services, conducting programs in the field of chronic disease, proper product-reconstitution and administration, and resources appropriate for support of disease management; educational services for product manufacturers, pharmaceutical clinicians and biotech companies, clinicians, contract research organizations and insurance providers, conducting classes, one-on-one sessions and telephonic workshops in the field of clinical education and distributing course materials in connection therewith; educational services, classes, one on one sessions and telephonic workshops which provide physicians, insurance companies and patients with specific characteristics associated with disease management products; educational services and resources, conducting workshops for children to help them to understand hemophilia; educational services, conducting workshops for children to help them understand hemophilia;pharmaceutical preparations for the treatment of chronic diseases, alpha-1 antitrypsin deficiency, moderate to severe persistent asthma, pulmonary arterial hypertension, respiratory syncytial virus, chronic, moderate to severe plaque psoriasis, hereditary tyrosinemia type 1, autoimmune disorders and primary immune deficiencies, growth hormone deficiency, fabry disease, rheumatoid arthritis, psoriatic arthritis, hemophilia, gaucher disease, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, multiple sclerosis, hypomobility associated with advanced parkinson's disease, mps 1, severe combined immunodeficiency disease, chronic granulomatour disease, severe malignant osterpetrosis; pharmaceutical preparations for use as blood clotting agents used in the control of hemophilia; pharmaceutical preparations for the treatment of chronic diseases, disorders requiring intravenous immunoglobulin therapy; pharmaceutical preparations for the treatment of hemophilia;printed publications, magazines featuring articles and information on blood disorders; newsletters and pamphlets featuring a series of stories on the subject of living with hemophilia; newsletters on the subject of hemophilia and related health issues;providing information about government benefits and entitlements, and insurance, and related social services to people with chronic diseases and other health conditions;retail pharmacy services specializing in the treatment and control of chronic diseases; retail pharmacy services specializing in the control of hemophilia;providing patient advocate services to people with chronic diseases and other health conditions regarding government benefits and entitlements, and insurance, and related social services;nursing care specializing in the treatment, prevention and control of chronic diseases; nursing care specializing in the treatment, prevention and control of hemophilia; medical services, administration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of hemophilia; administration of pharmaceutical preparations used in the treatment of chronic diseases; providing information concerning medical care and treatment in the field of hemophilia; disease management services; telephone hotline counseling, offering healthcare advice regarding bleeding disorders; services consisting of providing nutritional guidance and consultation to chronically ill patients; medical services, specialized pharmaceutical advice for individuals with bleeding disorders;health;providing clinical research in the field of medicine for product manufacturers, pharmaceutical and biotech companies, contract research organizations and insurance providers, and providing consulting services in support of new drug product launches; medical services, on-line analysis of infusion and bleeding activity for hemophiliacs;.

Its status is currently believed to be active. Its class is unavailable. “ACCREDO HEALTH” is believed to be currently owned by “ACCREDO HEALTH GROUP, INC.”